Back
ProShares UltraShort Financials Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
34
SKF
ProShares UltraShort Financials
Last Price:
$30.50
Seasonality Move:
-3.8%
Sell
33
ASND
Ascendis Pharma AS
Last Price:
$159.41
Seasonality Move:
2.56%
Sell
34
ProShares UltraShort Financials (SKF)
is a Sell
Is ProShares UltraShort Financials a Buy, Sell or Hold?
-
The current ProShares UltraShort Financials [SKF] share price is $30.51. The Score for SKF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
SKF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $159.24. The Score for ASND is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKF Stock Price Chart
What is ProShares UltraShort Financials's stock price today?
-
The ProShares UltraShort Financials share price today is $30.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $159.24The current trend is relatively stagnant and ASND is experiencing slight buying pressure.
SKF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.88 | Sell |
Relative Strength Index (14 RSI): | 43.58 | Sell |
Chaikin Money Flow: | 4209 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.91 - 32.81) | Sell |
Bollinger Bands (100): | (30.54 - 35.42) | Sell |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 50.04 | Buy |
Chaikin Money Flow: | 166728 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (156.48 - 166.42) | Sell |
Bollinger Bands (100): | (134.33 - 162.71) | Buy |
SKF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.2 | Buy |
20-day SMA: | 30.83 | Sell |
50-day SMA: | 33.21 | Sell |
200-day SMA: | 35.67 | Sell |
8-day EMA: | 30.44 | Buy |
20-day EMA: | 31.09 | Sell |
50-day EMA: | 32.36 | Sell |
200-day EMA: | 36.88 | Sell |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 159.52 | Sell |
20-day SMA: | 161.1 | Sell |
50-day SMA: | 158.22 | Buy |
200-day SMA: | 140.64 | Buy |
8-day EMA: | 159.36 | Sell |
20-day EMA: | 159.56 | Sell |
50-day EMA: | 156.8 | Buy |
200-day EMA: | 144.01 | Buy |
ProShares UltraShort Financials Earnings Growth & SKF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.
ProShares UltraShort Financials Technical Analysis
May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |